AdvisorShares Psychedelics Financial Statements From 2010 to 2024
| PSIL Etf | USD 12.18 0.27 2.27% |
Check AdvisorShares Psychedelics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among AdvisorShares Psychedelics' main balance sheet or income statement drivers, such as , as well as many indicators such as . AdvisorShares financial statements analysis is a perfect complement when working with AdvisorShares Psychedelics Valuation or Volatility modules.
AdvisorShares |
AdvisorShares Psychedelics ETF ETF Beta Analysis
AdvisorShares Psychedelics' Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current AdvisorShares Psychedelics Beta | 0.69 |
Most of AdvisorShares Psychedelics' fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, AdvisorShares Psychedelics ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, AdvisorShares Psychedelics ETF has a Beta of 0.69. This is much higher than that of the AdvisorShares family and significantly higher than that of the Miscellaneous Sector category. The beta for all United States etfs is notably lower than that of the firm.
About AdvisorShares Psychedelics Financial Statements
AdvisorShares Psychedelics investors utilize fundamental indicators, such as revenue or net income, to predict how AdvisorShares Etf might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. Advisorshares Psychedelics is traded on NYSEARCA Exchange in the United States.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of AdvisorShares Psychedelics Correlation against competitors. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.